SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Ron Oda who wrote (662)3/12/1998 2:51:00 AM
From: PACKRATCAT  Respond to of 1060
 
The best thing I did in 1997 was to drop Murphy's stock letter. I curse the day I subscribed. He has been wrong so long on this stock it serves as one of many examples of his folly.

To: Greg h2o (1952 )
From: DR. MEADE
Thursday, Feb 12 1998 10:07AM EST
Reply # of 1978

ichael Murphy is a man with a message: The ''New Economy'' is
technology, and investors stuck in the ''Old Economy'' are
destined to
be left behind.

It doesn't matter if you buy technology stocks or technology funds,
says
Murphy, the founder and editor of the well-known California
Technology
Stock Letter. The point is to buy technology - and BUY IT NOW!

Murphy was in town yesterday, hawking his vision and his book,
''Every
Investor's Guide to High-Tech Stocks and Mutual Funds''
(Broadway
Books), which is getting good ink in places such as The New
York Times
and Business Week. We know Murphy from his daily CNBC ads,
and somewhere
along the way yesterday we asked him what kind of numbers his
newsletter
put up last year and how it stacked up against the competition.

''I'm not sure. I just haven't seen them,'' said the 56-year-old
Murphy
curiously.

An investment letter writer not able to cite his most recent returns
is
a little like Wade Boggs not knowing his batting average. What's
the
chance of that?

Let's just say the numbers aren't what you want to take out on your
next
book tour.

In last year's roaring bull market, Murphy's model portfolio
produced a
loss of 36.7 percent while the Wilshire 5000 was up 31.3 percent.
That
ranked Murphy's letter number 140 of 142 newsletters followed
by Hulbert
Financial Digest, which has long tracked the advice business.

On the upside, this stock seems to have true merit and with an incredbile amount of patience there may be hope.

I will not sell on any announcement.

Matthew



To: Ron Oda who wrote (662)3/12/1998 10:25:00 PM
From: Robert Mayo  Read Replies (1) | Respond to of 1060
 
"...if the price rises after an announcement, there will be some selling by CTSL members and others that have been holding, but an announcement means new investors too."

There's a lot of pent-up demand to sell INSV. I suspect this will keep a lid on the stock price after any announcement, for a while anyway. Lots of disgruntled former CTSL subscribers are just waiting to bail.

I thought about doing that but have decided to wait. If Insite pulls this test kit deal off, a lot of the risk will be gone from the stock. In addition to an injection of cash from any partner(s), the kit should also produce a revenue stream well into the future. I figure if I sell at $5 or $6 I'll be leaving a lot on the table. So I'll just wait. Murphy's price target of $30/share may be rich, but the high teens seem a reasonable target.

Bob